The Lawrence Group studies the impact of inflammation in cancer progression with a particular focus on the biology of macrophages and dendritic cells. In collaboration with colleagues in the Schools of Immunology and Microbial Sciences, Dr. Subhankar Mukhopadhyay, and Cancer and Pharmaceutical Sciences, Dr. Shahram Kordasti and Dr James Arnold, we apply high-dimensional proteogenomic analyses and systems biology in preclinical models and clinical samples to unravel the mechanisms by which inflammatory cells such as macrophages and dendritic cells influence the initiation and progression of cancer and response to therapy. These projects are jointly co-ordinated with Dr. Lawrence’s group at the Centre d’Immunologie Marseille Luminy. The CIML is an internationally renowned Immunology research institute created by the CNRS, INSERM and Aix-Marseille-Université, located east of the city of Marseille in the south of France.
Current PhD students:
